Dr. Banshi Saboo MBBS , MD (Medicine), PhD, FACE, FRCP
Dia Care – Diabetes Care & Hormone Clinic
27 Years Experience
Dr. Banshi Saboo – Chief Diabetologist
MBBS, MD (Medicine), PhD, FACE, FRCP
Professional Summary
Dr. Banshi Saboo is an internationally acclaimed Chief Diabetologist based in Ahmedabad, Gujarat, with over 27 years of specialized experience in diabetes care, endocrinology, and metabolic medicine. As Founder and Chairman of Dia Care – Diabetes Care & Hormone Clinic, he has established himself as a global leader in diabetes research, clinical guidelines development, and innovative treatment protocols, serving as Chair-Elect of the International Diabetes Federation (IDF) South-East Asia.
Hospital Affiliation
Dia Care – Diabetes Care & Hormone Clinic, Ahmedabad
- Founder & Chief Diabetologist
- Comprehensive diabetes and endocrine specialty center
Specialization Areas
Advanced Diabetes Management
- Type 1 Diabetes with intensive insulin therapy and technology integration
- Type 2 Diabetes personalized treatment protocols
- Gestational Diabetes comprehensive care
- Pediatric and adolescent diabetes management
Diabetes Technology
- Continuous Glucose Monitoring (CGM) systems implementation
- Insulin pump therapy and automated insulin delivery
- Digital diabetes management platforms
- Advanced insulin delivery devices and protocols
Metabolic Medicine
- Metabolic syndrome and obesity management
- Lipid disorders and cardiovascular risk reduction
- Thyroid and hormonal disorder treatment
- Nutritional and lifestyle intervention programs
Diabetes Complications Management
- Diabetic nephropathy prevention and treatment
- Diabetic retinopathy screening and coordination
- Diabetic neuropathy comprehensive care
- Cardiovascular risk stratification and management
Treatment Philosophy
Dr. Saboo emphasizes a comprehensive, technology-enhanced approach to diabetes care:
- Evidence-based personalized treatment protocols
- Early adoption of advanced diabetes technology for optimal glycemic control
- Patient education and empowerment for self-management
- Multidisciplinary team collaboration with nutrition, psychology, and cardiology specialists
- Preventive care focus with community outreach and awareness programs
Advanced Services
-
Diabetes Technology Integration
CGM setup, training, and data interpretation
Insulin pump initiation and optimization
Automated insulin delivery system management -
Comprehensive Diabetes Care
Complete diabetes screening and staging
Advanced glycemic monitoring and adjustment
Complication screening and prevention protocols -
Research and Clinical Trials
Principal investigator for international diabetes studies
Access to latest diabetes medications and devices
Clinical research participation opportunities -
Digital Health Services
Telemedicine consultations and remote monitoring
Mobile app-based diabetes management
Digital patient education resources
Support Services
- Comprehensive diabetes self-management education (DSME)
- Certified diabetes educator consultations
- Nutritionist and dietitian services
- Diabetes support groups and community programs
- Digital health monitoring and follow-up care
Reopine Consultation Details
Available Services:
- ✅ First Opinion Consultations – Initial diabetes evaluation and diagnosis
- ✅ Second Opinion Reviews – Treatment optimization and technology assessment
- ✅ Advanced Diabetes Management – Complex case consultation and planning
- ✅ Technology Consultations – CGM, insulin pump, and digital health guidance
- ✅ Complication Management – Comprehensive diabetes complication care
- ✅ Research Consultation – Clinical trial eligibility and advanced treatment options
Languages Spoken:
- English (Fluent)
- Hindi (Fluent)
- Gujarati (Fluent)
Why Choose Dr. Banshi Saboo?
Professional Excellence
- ✅ 27+ years of specialized diabetes and endocrinology practice
- ✅ International recognition as Chair-Elect of IDF South-East Asia
- ✅ Research leadership in diabetes guidelines and clinical protocols
- ✅ Technology pioneer in advanced diabetes management systems
- ✅ Academic contributions with PhD and multiple medical fellowships
Patient-Centered Approach
- ✅ Comprehensive care from prevention through advanced complication management
- ✅ Technology integration for optimal diabetes control and monitoring
- ✅ Global standards of care with international best practices
- ✅ Community impact through diabetes awareness and prevention programs
- ✅ Innovative treatments with access to latest research and therapies
Book Your Consultation
Ready to receive world-class diabetes care from an internationally recognized expert? Dr. Banshi Saboo provides expert diabetes and endocrinology consultations through Reopine's secure virtual platform, offering cutting-edge treatment protocols, advanced technology integration, and comprehensive diabetes management strategies. Request your consultation today to access global-standard diabetes care and innovative treatment approaches.
Last Updated: September 2025
Profile prepared for Reopine
Date: 15 Feb 2026
-
Nature of Services
- I understand that Reopine is a technology platform that connects me with independent, licensed doctors in India for medical opinion/teleconsultation.
- I acknowledge that Reopine itself does not provide medical services, diagnosis, or treatment. All medical advice is given solely by the consulting doctor.
-
Teleconsultation Limitations
- I understand that teleconsultation has inherent limitations compared to in-person consultation, including lack of physical examination and limited access to diagnostic tests.
- I agree that the medical opinion provided may be limited by the information, history, and documents I provide.
-
Emergency Situations
- I acknowledge that Reopine is not to be used in emergency or life-threatening situations.
- In case of emergencies, I shall immediately contact local healthcare providers or emergency numbers (e.g., 108 in India / 911 in USA).
-
Cross-Border Consultations
- I understand that all doctors on Reopine are licensed to practice in India only.
- If I access the platform from outside India:
- I agree that the consultation is deemed to have occurred in India under Indian law.
- I accept full responsibility for compliance with my country’s local laws.
- I waive any claim against Reopine in foreign jurisdictions.
- The information provided during this consultation is for general health guidance and educational purposes only.
- It is not a substitute for an in-person medical examination by a doctor licensed in your country.
- The doctor may offer advice or general treatment options based on information you share, but you are strongly advised to:
- Consult a locally licensed physician before starting or changing any medication or treatment.
- The consultation is conducted based on good faith, relying on the accuracy and completeness of the information you provide.
-
Data Privacy
- I consent to Reopine collecting, processing, and storing my personal and medical information in accordance with its Privacy Policy and applicable Indian data protection laws.
- I understand that my health records may be shared with consulting doctors for the purpose of the consultation.
-
Payment, Refund & Liability
- I understand that payments made are subject to Reopine’s Cancellation & Refund Policy.
- I agree that Reopine’s liability, if any, shall be limited to the amount of service fees paid by me for the disputed consultation, and not exceeding INR 10,000 in any case.
- I acknowledge that any malpractice or negligence claim lies against the individual doctor, not against Reopine.
-
Consent & Acknowledgment
By proceeding, I confirm that:
- I have read and understood the Terms & Conditions and this Consent Form.
- I voluntarily consent to teleconsultation via Reopine.
- I release Reopine from liability for outcomes beyond its control, including medical opinions of independent doctors, third-party technology failures, or my own failure to follow medical advice.
Patient’s Full Name:
Signature: ____________________________
Date: 15 Feb 2026
Subcribe to our Newsletter
Subscribe for Updates: Stay informed about the latest investor updates, financial results, and announcements by subscribing to our newsletter.